ArticleScientific reports2025

A bispecific anti-MUC16/anti-death receptor 5 antibody achieves effective and tumor-selective death receptor 5-mediated tumor regression.

Victor S Goldmacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.